‘Hoping that the future of Indian Pharma is brighter than before’
Dr Ajit Dangi, President & CEO, Danssen Consulting
While most reforms carried out by the Modi Government in the past four…
Author
‘I expect more bold initiatives on macro-economic front’
Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates
The Modi Government has been following a policy of concentrating on macro…
‘Funding for pharma companies might be a way to move forward’
Dr Dinesh Dua, Chairman,Pharmexcil, Chairman, Entrepreneurship & Start Ups, CII North India,CEO & Director, Nectar…
‘There is a definite need to support SME upgradation’
Harish Jain, Secretary and Sunil Attavar, President, Karnataka Drugs & Pharmaceuticals Manufacturer’s Association
There is no…
‘We expect the new govt to reduce regulatory intervention’
BR Sikri, Chairman, Fope
First let me highlight the good things done by the present government.:
Recently agreed to publish SQ…
Lifesciences industry posts 53 deals worth $5.8 bn in April 2019
Novartis’ acquisition of IFM Therapeutics contribute 27 per cent to the total deal value
In April 2019, the healthcare industry…
Novartis’ innovative gene therapy for spinal muscular atrophy gets stronger
The interim results demonstrated prolonged event-free survival in Type 1 SMA patients who received the therapy as well as…
Formulation R&D leaders to congregate at FDD Conclave 2019 in Hyderabad
In its third edition, the conclave this year will focus on the theme: Preparing for the next frontiers in FDD
Organised by…
Ideas should be developed based on demands and objectives
Pharmaceutical industry is the second most regulated industry in the world and pharmaceutical products require standard packaging…
Packaging plays a key role to protect the pharma supply chain
Pharmaceutical industry’s approach today is more user centric and has personalised focus evolving from traditional methods.…